Genetic Technologies Limited
GNTLF
$1.00
$0.998990,809.09%
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.21% | -5.53% | |||
| Total Other Revenue | 0.22% | 20.71% | |||
| Total Revenue | 0.21% | -0.61% | |||
| Cost of Revenue | 0.21% | 15.13% | |||
| Gross Profit | 0.21% | -9.48% | |||
| SG&A Expenses | 0.21% | 2.80% | |||
| Depreciation & Amortization | 0.24% | -8.63% | |||
| Other Operating Expenses | 0.21% | -5.14% | |||
| Total Operating Expenses | 0.21% | 2.86% | |||
| Operating Income | -0.21% | -6.13% | |||
| Income Before Tax | -0.21% | 12.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.21% | 12.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.21% | 12.00% | |||
| EBIT | -0.21% | -6.13% | |||
| EBITDA | -0.21% | -6.98% | |||
| EPS Basic | 0.00% | 31.49% | |||
| Normalized Basic EPS | 0.00% | 14.44% | |||
| EPS Diluted | 0.00% | 31.49% | |||
| Normalized Diluted EPS | 0.00% | 14.44% | |||
| Average Basic Shares Outstanding | 0.00% | 29.11% | |||
| Average Diluted Shares Outstanding | 0.00% | 29.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
